-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Gain Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2024.
- Gain Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $19.9 K, a 18.8% increase year-over-year.
- Gain Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was $82.4 K, a 23.7% decline year-over-year.
- Gain Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $79.3 K, a 14.7% decline from 2022.
- Gain Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $93 K, a 2220% increase from 2021.
- Gain Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $4.01 K, a 25.6% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)